{"id":"W6977698662","doi":"10.6084/m9.figshare.c.7367241.v1","title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study","year":2024,"lang":"en","type":"other","venue":"Figshare","topic":"Probability and Statistical Research","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Pembrolizumab; Placebo; Lung cancer; Immunotherapy; Phases of clinical research; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004781624,0.001180203,0.00309197,0.0004652124,0.0001437534,0.0002329688,0.0006391475,0.0004222741,0.04263092],"category_scores_gemma":[0.001973849,0.0008236538,0.0005764718,0.0004322871,0.0001062805,0.00007647405,0.0002475022,0.0006014023,0.0002612361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001154979,"about_ca_system_score_gemma":0.002691155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001451576,"about_ca_topic_score_gemma":0.005860855,"domain_scores_codex":[0.9950175,0.000279357,0.001119005,0.00133106,0.001136334,0.001116689],"domain_scores_gemma":[0.9923541,0.004990917,0.0007084369,0.001004573,0.0004635614,0.0004784266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8619488,0.003660123,4.040209e-7,0.03002882,0.006847432,0.00053354,0.002851049,0.0001107371,0.000001064842,0.0009115595,0.09129818,0.001808286],"study_design_scores_gemma":[0.9625369,0.006357821,4.148702e-7,0.007253701,0.005915442,0.00001370157,0.0002439117,0.005038685,0.0003288957,0.002214628,0.009089869,0.001006078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"dataset","genre_gemma":"other","genre_scores_codex":[0.003475285,0.006708582,0.001706839,0.0001712105,0.0003491598,0.08070326,0.8755153,0.0004737163,0.03089667],"genre_scores_gemma":[0.1685548,0.0003678917,0.01694331,0.00003946722,0.001005026,0.1766756,0.0775148,0.004016532,0.5548826],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.7980005,"threshold_uncertainty_score":0.9994214,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2081530474279305,"score_gpt":0.4372120831167093,"score_spread":0.2290590356887788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}